Persistence of mild to moderate atopic dermatitis

JAMA Dermatol. 2014 Jun;150(6):593-600. doi: 10.1001/jamadermatol.2013.10271.


Importance: Atopic dermatitis (AD) is a common illness of childhood.

Objective: To evaluate the natural history of AD and determine the persistence of symptoms over time.

Design, setting, and participants: A cross-sectional and cohort study of a nation-wide long-term registry of children with AD enrolled in the Pediatric Eczema Elective Registry (PEER).

Main outcomes and measures: Self-reported outcome of whether a child's skin was AD symptom-free for 6 months at 6-month intervals.

Results: A total of 7157 patients were enrolled in the PEER study for a total of 22,550 person-years. At least 2 years of follow-up were observed for 4248 children and at least 5 years of follow-up were observed for 2416 children. Multiple demographic and exposure variables were associated with more persistent AD. At every age (ie, 2-26 years), more than 80% of PEER participants had symptoms of AD and/or were using medication to treat their AD. It was not until age 20 years that 50% of patients had at least 1 lifetime 6-month symptom- and treatment-free period.

Conclusions and relevance: Based on this large longitudinal cohort study, symptoms associated with AD seem to persist well into the second decade of a child's life and likely longer. Atopic dermatitis is probably a life-long illness.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cohort Studies
  • Dermatitis, Atopic / diagnosis*
  • Eczema / diagnosis
  • Female
  • Humans
  • Male
  • Prospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Young Adult